Sarah L. Roche

1.3k total citations
23 papers, 859 citations indexed

About

Sarah L. Roche is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Ophthalmology. According to data from OpenAlex, Sarah L. Roche has authored 23 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Ophthalmology. Recurrent topics in Sarah L. Roche's work include Retinal Development and Disorders (14 papers), Retinal Diseases and Treatments (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Sarah L. Roche is often cited by papers focused on Retinal Development and Disorders (14 papers), Retinal Diseases and Treatments (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Sarah L. Roche collaborates with scholars based in Ireland, United Kingdom and Spain. Sarah L. Roche's co-authors include Thomas H. Gillingwater, Thomas G. Cotter, Thomas M. Wishart, Maica Llavero Hurtado, Samantha L. Eaton, Karla J. Oldknow, Colin Farquharson, Jennifer N. Moloney, Gillian Hunter and Nicolás Cuenca and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Scientific Reports.

In The Last Decade

Sarah L. Roche

23 papers receiving 852 citations

Peers

Countries citing papers authored by Sarah L. Roche

Since Specialization

Citations

This map shows the geographic impact of Sarah L. Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah L. Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah L. Roche more than expected).

Fields of papers citing papers by Sarah L. Roche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah L. Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah L. Roche. The network helps show where Sarah L. Roche may publish in the future.

Co-authorship network of co-authors of Sarah L. Roche

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah L. Roche. A scholar is included among the top collaborators of Sarah L. Roche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah L. Roche. Sarah L. Roche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prevalence Rates of Primary Headache Disorders and Evaluation and Treatment Patterns Among Korean Neurologists 2022 ·Journal of Clinical Neurology ·Byung‐Kun Kim, Min Kyung Chu, (unknown), Grazia Dell’Agnello, Hans‐Peter Hundemer, (unknown), (unknown), Sarah L. Roche, (unknown), Soo‐Jin Cho	4
2	Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials 2021 ·Diabetes Obesity and Metabolism ·Esteban Jódar, Irene Romera, Qianqian Wang, Sarah L. Roche, Luis‐Emilio García‐Pérez	3
3	Selective Histone Deacetylase 6 Inhibitors Restore Cone Photoreceptor Vision or Outer Segment Morphology in Zebrafish and Mouse Models of Retinal Blindness 2020 ·Frontiers in Cell and Developmental Biology ·(unknown), Sarah L. Roche, Guinevere L. Grice, (unknown), (unknown), Giuseppe Campiani, James A. Nathan, Breandán N. Kennedy	24
4	Norgestrel, a Progesterone Analogue, Promotes Significant Long-Term Neuroprotection of Cone Photoreceptors in a Mouse Model of Retinal Disease 2019 ·Investigative Ophthalmology & Visual Science ·Sarah L. Roche, Oksana Kutsyr, Nicolás Cuenca, Thomas G. Cotter	19
5	Cell Death Analysis in Retinal Cultures 2018 ·Methods in molecular biology ·Sarah L. Roche, (unknown), Thomas G. Cotter	1
6	Fractalkine-CX3CR1 signaling is critical for progesterone-mediated neuroprotection in the retina 2017 ·Scientific Reports ·Sarah L. Roche, (unknown), (unknown), (unknown), Thomas G. Cotter	33
7	Nuclear membrane-localised NOX4D generates pro-survival ROS in FLT3-ITD-expressing AML 2017 ·Oncotarget ·Jennifer N. Moloney, Ashok Kumar Jayavelu, Joanna Stanicka, Sarah L. Roche, Rebecca L. O’Brien, Sebastian Scholl, (unknown), Thomas G. Cotter	13
8	Microglial‐induced Müller cell gliosis is attenuated by progesterone in a mouse model of retinitis pigmentosa 2017 ·Glia ·Sarah L. Roche, (unknown), Jennifer N. Moloney, (unknown), Thomas G. Cotter	59
9	The synthetic progestin norgestrel modulates Nrf2 signaling and acts as an antioxidant in a model of retinal degeneration 2016 ·Redox Biology ·(unknown), (unknown), Sarah L. Roche, Jennifer N. Moloney, (unknown), Thomas G. Cotter	23
10	Alterations to retinal architecture prior to photoreceptor loss in a mouse model of retinitis pigmentosa 2016 ·The International Journal of Developmental Biology ·Sarah L. Roche, (unknown), (unknown), (unknown), Thomas G. Cotter	27
11	Progesterone Attenuates Microglial-Driven Retinal Degeneration and Stimulates Protective Fractalkine-CX3CR1 Signaling 2016 ·PLoS ONE ·Sarah L. Roche, (unknown), Violeta Gómez‐Vicente, Pedro Lax, (unknown), (unknown), Nicolás Cuenca, Thomas G. Cotter	47
12	The synthetic progestin norgestrel acts to increase LIF levels in the rd10 mouse model of retinitis pigmentosa. 2016 ·PubMed ·(unknown), Sarah L. Roche, (unknown), (unknown), Thomas G. Cotter	19
13	Progesterone analogue protects stressed photoreceptors viabFGF‐mediated calcium influx 2016 ·European Journal of Neuroscience ·(unknown), Sarah L. Roche, (unknown), Jennifer N. Moloney, (unknown), Thomas G. Cotter	16
14	Progesterone receptor signalling in retinal photoreceptor neuroprotection 2015 ·Journal of Neurochemistry ·(unknown), Sarah L. Roche, (unknown), (unknown), Thomas G. Cotter	36
15	Canonical BMP–Smad Signalling Promotes Neurite Growth in Rat Midbrain Dopaminergic Neurons 2014 ·NeuroMolecular Medicine ·Shane V. Hegarty, Louise Collins, (unknown), Sarah L. Roche, Séan Wyatt, Aideen M. Sullivan, Gerard W. O’Keeffe	41
16	Loss of Glial Neurofascin155 Delays Developmental Synapse Elimination at the Neuromuscular Junction 2014 ·Journal of Neuroscience ·Sarah L. Roche, Diane L. Sherman, Kosala N. Dissanayake, Geneviève Soucy, Anne Desmazières, Douglas J. Lamont, Elior Peles, Jean‐Pierre Julien, Thomas M. Wishart, Richard R. Ribchester, Peter Brophy, Thomas H. Gillingwater	40
17	The influence of storage parameters on measurement of survival motor neuron (SMN) protein levels: Implications for pre-clinical studies and clinical trials for spinal muscular atrophy 2014 ·Neuromuscular Disorders ·Gillian Hunter, Sarah L. Roche, Eilidh Somers, Heidi R. Fuller, Thomas H. Gillingwater	5
18	A novel mouse model of Warburg Micro Syndrome reveals roles for RAB18 in eye development and organisation of the neuronal cytoskeleton 2014 ·Disease Models & Mechanisms ·Sarah M. Carpanini, Lisa McKie, Derek Thomson, Ann K. Wright, (unknown), Sarah L. Roche, Mark T. Handley, Harris Morrison, David G. Brownstein, Thomas M. Wishart, Michael A. Cousin, Thomas H. Gillingwater, Irene A. Aligianis, Ian J. Jackson	35
19	Total Protein Analysis as a Reliable Loading Control for Quantitative Fluorescent Western Blotting 2013 ·PLoS ONE ·Samantha L. Eaton, Sarah L. Roche, Maica Llavero Hurtado, Karla J. Oldknow, Colin Farquharson, Thomas H. Gillingwater, Thomas M. Wishart	321
20	SMN-dependent intrinsic defects in Schwann cells in mouse models of spinal muscular atrophy 2013 ·Human Molecular Genetics ·Gillian Hunter, (unknown), Sarah L. Roche, (unknown), Thomas H. Gillingwater	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact